Overview

Toripalimab Combined With Double Platinum Based Chemotherapy for Potentially Resectable Non-driver Gene Mutation Non-small Cell Lung Cancer

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study was to investigate the safety and efficacy of Toripalimab Combined With Double Platinum Based Chemotherapy for Potentially Resectable Non-driver Gene Mutation Non-small Cell Lung Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Yongchang Zhang